39,710 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Jupiter Topco LLC

Jupiter Topco LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 39,710 shares of the company’s stock, valued at approximately $1,172,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. Hsbc Holdings PLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $1,045,000. Palisade Capital Management LP acquired a new position in shares of Acadia Healthcare in the second quarter worth approximately $13,494,000. Legal & General Group Plc bought a new stake in Acadia Healthcare in the second quarter valued at approximately $6,127,000. The Manufacturers Life Insurance Company acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $1,324,000. Finally, Algert Global LLC acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $2,723,000.

Acadia Healthcare Trading Down 0.9%

NASDAQ ACHC opened at $28.13 on Friday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The business has a 50 day moving average price of $30.70 and a 200-day moving average price of $26.51. The company has a market cap of $2.62 billion, a price-to-earnings ratio of -2.26, a P/E/G ratio of 9.06 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.Acadia Healthcare’s quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the business earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ACHC has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Guggenheim lifted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. UBS Group upped their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Finally, Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.